Osseous sarcoidosis

Zain Gowani, Vasanth Sathiyakumar, Ginger E. Holt

Research output: Contribution to journalReview article

Abstract

» Most patients with osseous sarcoidosis present in their early forties, with a higher proportion being African-American. Typical clinical presentation is characterized by localized pain and swelling, most commonly in the vertebrae and the small bones of the hands and feet; the most common associated extraosseous symptoms are lymphadenopathy and pulmonary involvement. » Biopsies are mandatory for confirming a diagnosis of osseous sarcoidosis, but imaging modalities may be useful adjuncts. Radiographs may show lytic, sclerotic, or mixed patterns, and magnetic resonance imaging (MRI) studies may reveal typical T1 and T2 findings useful for monitoring lesion regression. Laboratory studies used in diagnosing or following extraosseous manifestations of sarcoidosis are not reliable for osseous sarcoidosis. » Corticosteroids are the first line of treatment for symptomatic, nonstructural osseous sarcoidosis. For refractory cases, adjuvant therapies may need to be added, including immunomodulators (methotrexate or tumor necrosis factor [TNF] alpha inhibitors) and nonsteroidal anti-inflammatory drugs (NSAIDs). Indications for operative intervention include irreversible bone pain, hypercalcemia, and radiographic evidence of severe cortical destruction. » For patients with isolated osseous lesions without a prior diagnosis of sarcoidosis, the orthopaedic surgeon should perform a thorough evaluation for extraosseous manifestations of sarcoidosis through a multimodal approach and should recommend vigilant follow-up.

Original languageEnglish (US)
Article numbere3
Pages (from-to)1-12
Number of pages12
JournalJBJS reviews
Volume3
Issue number4
DOIs
StatePublished - Apr 1 2015
Externally publishedYes

Fingerprint

Sarcoidosis
Foot Bones
Hand Bones
Pain
Immunologic Factors
Hypercalcemia
Methotrexate
African Americans
Adrenal Cortex Hormones
Spine
Anti-Inflammatory Agents
Tumor Necrosis Factor-alpha
Magnetic Resonance Imaging
Biopsy
Bone and Bones
Lung
Therapeutics
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

Gowani, Z., Sathiyakumar, V., & Holt, G. E. (2015). Osseous sarcoidosis. JBJS reviews, 3(4), 1-12. [e3]. https://doi.org/10.2106/JBJS.RVW.N.00082

Osseous sarcoidosis. / Gowani, Zain; Sathiyakumar, Vasanth; Holt, Ginger E.

In: JBJS reviews, Vol. 3, No. 4, e3, 01.04.2015, p. 1-12.

Research output: Contribution to journalReview article

Gowani, Z, Sathiyakumar, V & Holt, GE 2015, 'Osseous sarcoidosis', JBJS reviews, vol. 3, no. 4, e3, pp. 1-12. https://doi.org/10.2106/JBJS.RVW.N.00082
Gowani Z, Sathiyakumar V, Holt GE. Osseous sarcoidosis. JBJS reviews. 2015 Apr 1;3(4):1-12. e3. https://doi.org/10.2106/JBJS.RVW.N.00082
Gowani, Zain ; Sathiyakumar, Vasanth ; Holt, Ginger E. / Osseous sarcoidosis. In: JBJS reviews. 2015 ; Vol. 3, No. 4. pp. 1-12.
@article{9a72022e15f64be6a55ce8c463593720,
title = "Osseous sarcoidosis",
abstract = "» Most patients with osseous sarcoidosis present in their early forties, with a higher proportion being African-American. Typical clinical presentation is characterized by localized pain and swelling, most commonly in the vertebrae and the small bones of the hands and feet; the most common associated extraosseous symptoms are lymphadenopathy and pulmonary involvement. » Biopsies are mandatory for confirming a diagnosis of osseous sarcoidosis, but imaging modalities may be useful adjuncts. Radiographs may show lytic, sclerotic, or mixed patterns, and magnetic resonance imaging (MRI) studies may reveal typical T1 and T2 findings useful for monitoring lesion regression. Laboratory studies used in diagnosing or following extraosseous manifestations of sarcoidosis are not reliable for osseous sarcoidosis. » Corticosteroids are the first line of treatment for symptomatic, nonstructural osseous sarcoidosis. For refractory cases, adjuvant therapies may need to be added, including immunomodulators (methotrexate or tumor necrosis factor [TNF] alpha inhibitors) and nonsteroidal anti-inflammatory drugs (NSAIDs). Indications for operative intervention include irreversible bone pain, hypercalcemia, and radiographic evidence of severe cortical destruction. » For patients with isolated osseous lesions without a prior diagnosis of sarcoidosis, the orthopaedic surgeon should perform a thorough evaluation for extraosseous manifestations of sarcoidosis through a multimodal approach and should recommend vigilant follow-up.",
author = "Zain Gowani and Vasanth Sathiyakumar and Holt, {Ginger E.}",
year = "2015",
month = "4",
day = "1",
doi = "10.2106/JBJS.RVW.N.00082",
language = "English (US)",
volume = "3",
pages = "1--12",
journal = "JBJS Reviews",
issn = "2329-9185",
publisher = "Journal of Bone and Joint Surgery Inc.",
number = "4",

}

TY - JOUR

T1 - Osseous sarcoidosis

AU - Gowani, Zain

AU - Sathiyakumar, Vasanth

AU - Holt, Ginger E.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - » Most patients with osseous sarcoidosis present in their early forties, with a higher proportion being African-American. Typical clinical presentation is characterized by localized pain and swelling, most commonly in the vertebrae and the small bones of the hands and feet; the most common associated extraosseous symptoms are lymphadenopathy and pulmonary involvement. » Biopsies are mandatory for confirming a diagnosis of osseous sarcoidosis, but imaging modalities may be useful adjuncts. Radiographs may show lytic, sclerotic, or mixed patterns, and magnetic resonance imaging (MRI) studies may reveal typical T1 and T2 findings useful for monitoring lesion regression. Laboratory studies used in diagnosing or following extraosseous manifestations of sarcoidosis are not reliable for osseous sarcoidosis. » Corticosteroids are the first line of treatment for symptomatic, nonstructural osseous sarcoidosis. For refractory cases, adjuvant therapies may need to be added, including immunomodulators (methotrexate or tumor necrosis factor [TNF] alpha inhibitors) and nonsteroidal anti-inflammatory drugs (NSAIDs). Indications for operative intervention include irreversible bone pain, hypercalcemia, and radiographic evidence of severe cortical destruction. » For patients with isolated osseous lesions without a prior diagnosis of sarcoidosis, the orthopaedic surgeon should perform a thorough evaluation for extraosseous manifestations of sarcoidosis through a multimodal approach and should recommend vigilant follow-up.

AB - » Most patients with osseous sarcoidosis present in their early forties, with a higher proportion being African-American. Typical clinical presentation is characterized by localized pain and swelling, most commonly in the vertebrae and the small bones of the hands and feet; the most common associated extraosseous symptoms are lymphadenopathy and pulmonary involvement. » Biopsies are mandatory for confirming a diagnosis of osseous sarcoidosis, but imaging modalities may be useful adjuncts. Radiographs may show lytic, sclerotic, or mixed patterns, and magnetic resonance imaging (MRI) studies may reveal typical T1 and T2 findings useful for monitoring lesion regression. Laboratory studies used in diagnosing or following extraosseous manifestations of sarcoidosis are not reliable for osseous sarcoidosis. » Corticosteroids are the first line of treatment for symptomatic, nonstructural osseous sarcoidosis. For refractory cases, adjuvant therapies may need to be added, including immunomodulators (methotrexate or tumor necrosis factor [TNF] alpha inhibitors) and nonsteroidal anti-inflammatory drugs (NSAIDs). Indications for operative intervention include irreversible bone pain, hypercalcemia, and radiographic evidence of severe cortical destruction. » For patients with isolated osseous lesions without a prior diagnosis of sarcoidosis, the orthopaedic surgeon should perform a thorough evaluation for extraosseous manifestations of sarcoidosis through a multimodal approach and should recommend vigilant follow-up.

UR - http://www.scopus.com/inward/record.url?scp=84988723845&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988723845&partnerID=8YFLogxK

U2 - 10.2106/JBJS.RVW.N.00082

DO - 10.2106/JBJS.RVW.N.00082

M3 - Review article

AN - SCOPUS:84988723845

VL - 3

SP - 1

EP - 12

JO - JBJS Reviews

JF - JBJS Reviews

SN - 2329-9185

IS - 4

M1 - e3

ER -